With this feasibility study, we show the successful optical molecular imaging of CAIX- and HER2-positive DCIS xenografts employing a combination of two tumour-specific VHHs, in vivo, in the mimicked surgical setting, as well as ex vivo on tumour sections. Here, ERBB2 is linked to neoplasm.